F.A.Z. Wissen

By Frankfurter Allgemeine ZeitungScience Natural Sciences Nature

Favorites
80
Followers
Typical duration
35 min
per episode

Based on Podcast App listening data

F.A.Z. Wissen episodes

February 04, 2022Warum Impfen keine nationale Angelegenheit ist
FAZ Wissen
Impfgerechtigkeit:
Modellstudie: Ye et al.: "Equitable access to COVID-19 vaccines makes a life-saving difference to all countries", Nature Human Behaviour, 31.1.2022
Kommentar von Samba Sow: "Global South cannot just live with COVID-19"
Kommentar von Keymanthri Moodley: "Vaccine inequity is unethical"
Kommentar von Tahir Amin: "Innovation alone won’t end COVID-19"
Kommentar von Philani Mthembu: "Travel bans erode global trust"
Kommentar von Anuradha Gupta: "COVAX can still end COVID-19 vaccine apartheid"
Kommentar von Ayoade Alakija: "Global North and South must work hand in glove to stop COVID-19"
Kommentar von Winnie Byanyima "HIV or COVID-19, inequity is deadly"
Correspondence von Achal Prabhala und Alain Alsalhani "Developing countries can make the mRNA vaccines they need"
Hörerfragen:
Zu Fragen der Blutwäsche:
"Hilferufe aus den Blutgefässen": FAZ.NET v. 5.1.2022
Zu Impfungen und Infektionen:
Aus unserem Podcast "Brauchen Genesene jetzt noch eine Impfung" die Genfer Immunitätsstudie
Fragen von Betroffenen zu Long-Covid: Patienten-Leitlinie des AWMF
37 min
January 28, 2022Schafft das Virus ein Heer von chronisch Kranken?
FAZ Wissen
Die Paper für diese Podcast-Folge:
Zum Nutzen der Impfung:
Paul Kuodi et al, medRxiv (Preprint), 2022: "Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021"
Ziyad Al-Aly et al, Research Square (Preprint), 2021, "Long Covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19"
Früherkennung von Long-Covid/Post-Covid:
Carlo Cervia et al, Nature Communications, 2022, "Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome"
Persistenz der Viren im Körper:
Daniel Chertow et al, Research Square (Preprint), 2021, "SARS-CoV-2 infection and persistence throughout the human body and brain"
Kjetil Bjoernevik et al, Science, 2022, "Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis"
45 min
January 20, 2022Brauchen Genesene jetzt noch eine Impfung?
FAZ Wissen
Die Paper zu dieser Podcast-Folge:
Coronavirus Infection Survey des britischen Office for National Statistics, 19. Januar 2022, "Characteristics of people testing positive for COVID-19"
Krammer-Studie/USA:
Juan M. Carreno et al, Nature, 31.12.2021, "Activity of convalescent and vaccine serum
against SARS-CoV-2 Omicron"
Eckerle-Studie / Genf:
Meriem Bekliz et al, Preprint 2022, "Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants"
Innsbruck-Studie:
Annika Rössler et al, New England Journal of Medicine, 20. Januar 2022, "SARS-CoV-2 Omicron Variant Neutralization in Serum
from Vaccinated and Convalescent Persons"
Südafrika-Studie:
Khadija Khan et al, Preprint, 2022, "Omicron infection enhances neutralizing immunity against the Delta variant"
Kanada-Studie:
ArinjayBanerjee et al, bioRxiv, 13. Januar 2022, "Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants"
Kalifornien-Studie:
Benjamin Sievers et al, Science Translational Medicine, 13. Januar 2022, "Antibodies elicited by SARS-CoV-2 infection or mRNA
vaccines have reduced neutralizing activity against Beta
and Omicron pseudoviruses"
48 min
January 14, 2022Ist Omikron etwa ein harmloses Virus?
FAZ Wissen
Die Paper zu dieser Podcast-Folge:
Kinder-Studie aus USA_
Lindsay Wang et al, medRxiv, 2022, "COVID infection severity in children under 5 years old before and after Omicron emergence in the US"
Virus-Dynamik im Harvard-Dashboard
Stephen Kissler et al, 2022, "Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant"
Genfer-Omikron-Studie
Olha Puuhach et al, medRxiv, 2022, "Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron"
Wissenschaftler-Aufruf
British Medical Journal, 14. Januar 2022, "Europe must come together to confront omicron"
T-Zellabwehr
Heidi Ledford, Nature, 2022, "‘Killer’ immune cells still recognize Omicron variant"
45 min
December 30, 2021 Zum Mond und noch weiter
FAZ Wissen
Die Links zu den Missionen:
Artemis:
https://www.esa.int/Science_Exploration/Human_and_Robotic_Exploration/Exploration/Gateway
https://www.nasa.gov/sites/default/files/atoms/files/artemis_plan-20200921.pdf
Russische Mondmission Luna 25:
https://nssdc.gsfc.nasa.gov/nmc/spacecraft/display.action?id=LUNA-25
https://www.esa.int/Science_Exploration/Human_and_Robotic_Exploration/Exploration/Luna
Japanische Mission SLIM:
https://global.jaxa.jp/projects/sas/slim/
https://nssdc.gsfc.nasa.gov/nmc/spacecraft/display.action?id=SLIM
Indische Mondmission Chandrayaan-3: https://nssdc.gsfc.nasa.gov/nmc/spacecraft/display.action?id=CHANDRYN3
Südkoreanische Mondmission Korea Pathfinder Lunar Orbiter: https://nssdc.gsfc.nasa.gov/nmc/spacecraft/display.action?id=KPLO
Asteroidenmission Psyche: https://solarsystem.nasa.gov/missions/psyche/in-depth/
Asteroidenmission Lucy: https://solarsystem.nasa.gov/missions/lucy/in-depth/
Asteroidenmission DART: https://www.nasa.gov/planetarydefense/dart
ExoMars: https://www.dlr.de/rd/desktopdefault.aspx/tabid-2448/3635_read-59249/
Ariane 6:
https://www.dlr.de/rd/desktopdefault.aspx/tabid-2279/3410_read-47667/
Vega-C: https://www.esa.int/Enabling_Support/Space_Transportation/Launch_vehicles/Vega-C
SpaceX Starship: https://www.spacex.com/vehicles/starship/
48 min
December 16, 2021 Können unsere Immunzellen Omikron in Schach halten?
FAZ Wissen
Die Paper zu dieser Podcast-Folge:
Brian Laidlaw et al, Nature Reviews Immunology, 2021, "The germinal centre B cell response to SARS-CoV-2"
Wilfredo Garcia Beltran et al,
meRxiv, 2021, "mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant"
Sarah Adamo, Nature, 2021, "Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection"
Lucy Loyal, Andreas Thiel et al, Science, 2021, "Cross-reactive CD4+T cells enhance SARS-CoV-2 immune responses upon infection and vaccination"
Andrew Redd et al, bioRxiv, 2021, "Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals"
42 min
December 10, 2021Wie informieren sich Menschen in der Pandemie?
FAZ Wissen
Vergleich Pandemie und Infodemie:
S. Briand et al.: "Infodemics: A new challenge for public health", Cell, 9.12.21
Was bestimmt das Interesse an neuen Informationen?
C. Kelly & T. Sharot: "Individual differences in information-seeking", Nature Communications, 3.12.21
Vorschlag von Mega-Studien:
K. Milkman et al.: "Megastudies improve the impact of applied behavioural science", Nature, 8.12.21
Positionspapier des Wissenschaftsrates:
Wissenschaftskommunikation | Positionspapier (Drs. 9367-21), Oktober 2021
36 min
December 03, 2021Beginnt mit Omikron ein neues Pandemie-Kapitel?
FAZ Wissen
Die Paper zu diesem Podcast:
Juliet Pulliam et al, medRxiv, 2021, "Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa"
Salim S. Karim et al, Lancet, 2021, "Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic"
Aktueller Situationsbericht des Scripps Institute:
"Outbreak Info"
Multicenter-Studie zur Wirksamkeit der Booster:
Alasdair Munroe et al, Lancet, 2021, "Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial"
34 min
November 29, 2021Was kann die vierte Welle stoppen?
FAZ Wissen
Überblick Studie zur Wirksamkeit pandemischer Maßnahmen:
A. Mendez-Brito, C. El Bcheraoui, F. Pozo-Martin: „Systematic review of empirical studies comparing the effectiveess of non-pharmaceutical interventions against Covid-19”, Journal of Infection, 19.6.2021
Lockdown-Müdigkeit in England:
S. Ross et al.: „Household visitation curing the Covid-19 pandemic“, Scientific Reports, 25.11.2021
Beitrag der Ungeimpften zum Infektionsgeschehen in Deutschland:
B. Maier, … , Cornelia Betsch, D. Brockmann: “Germany’s current Covid-19 crisis is mainly driven by the unvaccinated”, medRxiv preprint, 26.11.2021
43 min
November 18, 2021Wirken die Corona-Impfstoffe überhaupt noch gut genug?
FAZ Wissen
Die Paper zu dieser Podcast-Folge:
Fragwürdiges Harvard-Paper inkl. Faktencheck:
S. V. Subramanian et al, European Hournal of Epidemiology, 2021, "Increases in COVID‑19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States"
AFP-Faktencheck: "Studienautor dementiert: Diese Havard-Studie belegt nicht die Wirkungslosigkeit von Corona-Impfungen"
Schwedische Studie zu nachlassender Immunität:
Peter Nordström et al, Lancet-Preprint, 2021, "Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study"]
Israelische Studie zu mRNA-Booster:
Noam Barda et al, Lancet, 2021, "Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study"
Englische Studie zu Boostern:
Nick Andrews et al, Preprint medRxiv, "Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study"
Saarland-Studie zu Kreuzimpfungen:
Martina Sester et al, Preprint Research Square, 2021, "Immunogenicity and reactogenicity of heterologous Ad26.COV.2 and BNT162b2 vaccination"
46 min

About F.A.Z. Wissen

From the publisher's feed

So spannend kann Wissenschaft sein: Verständlich und anregend sprechen die F.A.Z.-Wissenschaftsredakteure Piotr Heller und Joachim Müller-Jung sowie die Feuilleton-Redakteurin Petra Ahne im Wechsel mit Gästen über aktuelle Themen und Studien, die ein breites Publikum interessieren. Thematisch umfasst dies alles von Natur und Klima bis KI und digitale Welten, Medizin und Ernährung, Hirnforschung, Weltraum und kurioses Alltagswissen bis hin zu wissenschaftspolitischen Zukunftsfragen, die insbesondere auch junge Menschen betreffen.